Document is current
Any future updates will be listed below
-
Authors
Johmura, Yoshikazu https://orcid.org/0000-0002-6812-9607
Wang, Teh-Wei
Nakanishi, Makoto https://orcid.org/0000-0002-6707-3584
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP23zf0127003h)
- License Information
-
More Information
Article History
Received: 2 July 2025
Revised: 16 September 2025
Accepted: 10 March 2026
First Online: 3 April 2026
Disclosure and competing interests statement
: MN is a scientific advisor and a shareholder of reverSASP Therapeutics.
